Award

Single-cell characterization of somatic mutations in congenital heart disease and aging heart

Description: Congenital heart disease (CHD) is the most common birth anomaly, affecting 0.4% to 1% of the population. Although recent studies have identified numerous variants and genes associated with CHD, the underlying mechanisms remain unclear in most cases. This significant knowledge gap may be partly due to a focus on germline mutations, often overlooking the role of somatic mutations, and the challenge of linking genetic variants to their functional impacts. To address these issues and to better understand CHD pathogenesis, our collaborators have developed the “Duplex-Multiome” method, which uses duplex sequencing to detect mutations in open chromatin while capturing both transcriptomic and chromatin accessibility landscapes in the same single cells at a reduced cost. I have already constructed a preliminary computational pipeline for the Duplex-Multiome protocol, which has shown promising results in both mutation detection and transcriptome analysis. In Aim 1, I will develop an integrated computational pipeline to process Duplex-Multiome data to generate high-quality mutation call sets, gene expression matrices, and chromatin accessibility profiles, and to estimate somatic mutation burdens and identify mutational spectra across various cell types. I will validate this pipeline by applying it to heart samples of various ages and compare the results with published cardiomyocyte mutation data. If successful, I will expand the analysis to all cell types, which will provide insights into the rates and mechanisms of somatic mutation accumulation in different cell types in the human heart. Building on the capabilities of Duplex-Multiome, my Aim 2 is to characterize mutational patterns in CHD patients across different heart cell types, and to investigate the effects of clonal somatic mutations on gene regulation in CHD. This will enhance our understanding of the causes of CHD and potentially lead to the development of novel therapeutic approaches. Overall, my goal is to uncover the cell-type-specific patterns and functional impacts of somatic mutations in the human heart aging and CHD. Ultimately, this could inform clinical studies on aging, CHD, and other cardiovascular disorders.
Amount: $69,550
Funding type: training
Funder scheme: Predoctoral Fellowship
Start date: 2025-01-01
End date: 2026-12-31
Investigator: Shulin Mao (lead)
Institutions: Harvard University, President and Fellows of Harvard College, Harvard Medical School
Funded outputs count: 0
Funder award ID: 25PRE1356998
OpenAlex ID: G1462273242